Sanofi SA
XHAM:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
QuoteMedia Inc
OTC:QMCI
|
US |
|
F
|
Fuji Die Co Ltd
TSE:6167
|
JP |
|
M
|
MedMira Inc
OTC:MMIRF
|
CA |
|
A
|
Asia Pioneer Entertainment Holdings Ltd
HKEX:8400
|
MO |
|
M
|
Metavisio SA
PAR:ALTHO
|
FR |
|
Tombola Gold Ltd
ASX:TBA
|
AU |
|
Goliath Film and Media Holdings
OTC:GFMH
|
US |
|
Hydromer Inc
OTC:HYDI
|
US |
|
T
|
Times Universal Group Holdings Ltd
HKEX:2310
|
HK |
|
M
|
My City Builders Inc
OTC:MYCB
|
US |
|
C
|
Capgemini SE
XHAM:CGM
|
FR |
|
F
|
Fourace Industries Group Holdings Ltd
HKEX:1455
|
CN |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Onconetix Inc
NASDAQ:ONCO
|
US |
|
Wisdom Education International Holdings Company Ltd
HKEX:6068
|
CN |
|
N
|
Navan Inc
NASDAQ:NAVN
|
US |
|
International Endeavors Corp
OTC:IDVV
|
US |
|
S
|
Sable Exploration and Mining Ltd
JSE:SXM
|
ZA |
|
AllDigital Holdings Inc
OTC:ADGL
|
US |
|
Freewon China Co Ltd
SSE:688678
|
CN |
|
G
|
Guangzhou Rural Commercial Bank Co Ltd
HKEX:1551
|
CN |
|
C
|
Chu Kong Petroleum and Natural Gas Steel Pipe Holdings Ltd
HKEX:1938
|
CN |
|
M
|
Medcamp SA
WSE:MDP
|
PL |
Multiples-Based Value
The Multiples-Based Value of one
SNW
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 82.47 EUR,
Sanofi SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SNW Competitors Multiples
Sanofi SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
XHAM:SNW
|
99.8B EUR | 2.1 | 12.8 | 10.6 | 10.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD | 13.5 | 42.7 | 28.8 | 30.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD | 6.2 | 21.9 | 15.2 | 18.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP | 5.4 | 31.2 | 17.2 | 24.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.6 | 16.4 | 10.1 | 12.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD | 2.6 | 20.6 | 7.9 | 10.5 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD | 2.5 | 17 | 7.2 | 8.8 |